FDA to meet with Japanese representatives
Executive Summary
Office of Drug Research and Review Director Robert Temple, MD, and Office of Biologics Research and Review Deputy Director James Bilstad, MD, are among FDAers who will meet with three representatives from Japan's Ministry of Health and Welfare May 28-29. Topics of discussion will include FDA's criteria for acceptance of clinical data, in vitro testing, and human growth hormone.